Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Influenza, Human × Nivolumab × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 75 Colorectal Neoplasms 70 Stomach Neoplasms 53 Pancreatic Neoplasms 49 Carcinoma, Non-Small-Cell Lung 40 Melanoma 29 Carcinoma, Renal Cell 26 Neoplasm Metastasis 23 Neoplasms 22 Esophageal Neoplasms 22 Squamous Cell Carcinoma of Head and Neck 19 Colonic Neoplasms 18 Carcinoma, Transitional Cell 18 Liver Neoplasms 17 Adenocarcinoma Of Esophagus 16 Ovarian Neoplasms 15 Esophageal Squamous Cell Carcinoma 15 Triple Negative Breast Neoplasms 14 Breast Neoplasms 13 Rectal Neoplasms 12 Biliary Tract Neoplasms 12 Uterine Cervical Neoplasms 11 Cholangiocarcinoma 11 Carcinoma, Merkel Cell 11 Lung Neoplasms 10 Head and Neck Neoplasms 10 Small Cell Lung Carcinoma 8 Gastrointestinal Neoplasms 8 Carcinoma 7 Adenocarcinoma 7

Interventions

Influenza Vaccines 2 Nivolumab 1 Ipilimumab 1 Gastroscopy 1 Colonoscopy 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05116917 2024-05-28

INFLUENCE

Herlev Hospital

Phase 2 Terminated

Gastrointestinal

Influenza, Human, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡